Navigation Links
Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Date:8/19/2007

convertible security - - - (12,215)

Investment and other income 482 294 797 417

Change in fair value of

derivative instruments (2,401) (56) 1,123 (7,620)

Interest expense (643) (573) (1,267) (1,140)

Total other (expense)

and income (2,562) (335) 653 (20,558)

Net (loss) income $(12,104) $(3,757) $(15,991) $(30,593)

Net (loss) income per

share, basic $(0.43) $(0.14) $(0.57) $(1.23)

Net (loss) income per

share, diluted $(0.43) $(0.14) $(0.60) $(1.23)

Weighted average shares

outstanding, basic 28,313,056 25,952,342 28,305,810 24,815,680

Weighted average shares

outstanding, diluted 28,313,056 25,952,342 28,403,507 24,815,680

EMISPHERE TECHNOLOGIES, INC.

Condensed Balance Sheets (Unaudited)

As of June 30, 2007 and December 31, 2006

(in thousands)

June 30, December 31,

2007 2006

Assets:

Cash, cash equivalents, restricted cash and

investments $8,939 $21,533

Accounts receivable 487 216

Prepaid expenses and other current assets 893 1,082

Total current assets 10,319 22,831

Equipment and leasehold improvements, net 2,247 2,652

Purchased technology, net 1,675 1,794

Other assets 798 815

Total A
'/>"/>

SOURCE Emisphere Technologies, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...The Study Demonstrates microRNAs Extracted From a ...ffective Clinical Biomarkers for a Wide Range of ... Proprietary Technology, Rosetta Genomics is Curre...o Detect Colon Cancer, REHOVOT, Israel and JERSEY...ll/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a lea...
(Date:9/4/2008)...nother Roche first in TaqMan(R) real-time PCR test... lab, PLEASANTON, Calif., Sept. 4 /PRNewswir...s approved the Roche COBAS(R) TaqMan(R) HBV Test,... DNA approved in the U.S.,The test uses Roche,s re...epatitis B virus DNA in a patient,s blood. Doctors...
(Date:9/4/2008)...ivotal Study Seeks to Enroll 750 Women at More Tha...4 /- QuatRx Pharmaceuticals, a,privat...lopment and,commercialization of compounds to trea...s, today announced that it has initiated a second,...ablets), the company,s,estrogen-free oral therapy ...
(Date:9/4/2008)... Optimizing Patient Identification for Ta... of Personalized Treatment HUNTINGTON BEACH, Ca...ire/ -- Agendia, a world leader in molecular cance...tPrint(R), a new diagnostic test that,allows physi...ion levels of,the estrogen receptor (ER), progeste...
Breaking Medicine Technology:Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2DiObex and Camurus Sign License Agreement for the Development of DIO 901 in FluidCrystal 28R 29 Extended Release Technology 4031 1DiObex and Camurus Sign License Agreement for the Development of DIO 901 in FluidCrystal 28R 29 Extended Release Technology 4031 2Jazz Pharmaceuticals Inc Announces Expansion of Senior Debt 4030 1Jazz Pharmaceuticals Inc Announces Expansion of Senior Debt 4030 2Misys and Allscripts Create a Leader in Healthcare Software 4027 1Reducing HD risk naturally post menopause 14530 1Reducing HD risk naturally post menopause 14530 2
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...epressants increase the risk of a gastrointestinal...reuptake inhibitors (SSRIs) are a group of antidep...e preferred over older drugs because they are rela...at Ottawa Hospital in Canada have just shown, they...
... that they "enjoy" their habit and don't fear the ...king involves powerful physiological and psycholog...ithout help only a minority succeed. Even smoking ...e helpful to many, have been unable to keep the ma...
...twice as likely to have a better quality of life a...uggests. Researchers in a Swiss study looked at pa... chronic angina. Doctors either gave them medicat...ty - a treatment where a fine tube with a small in...
...Centre and the Pentagon could affect the mental he... the dust settles over New York and Washington, ps...e full psychological impact of the disaster. Keepi...al keeps anxiety and grief at bay. And the sheer s...
Other Medicine News:
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: